Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 15,662 | 26,752 | 19,794 | 8,508 | 450 |
| Depreciation Amortization | 17,234 | 61,550 | 44,474 | 27,484 | 10,493 |
| Accounts receivable | -9,836 | -10,367 | -3,513 | -8,242 | -12,474 |
| Accounts payable and accrued liabilities | -1,350 | 3,769 | 244 | 1,935 | -108 |
| Other Working Capital | -20,131 | -25,299 | -15,079 | -13,238 | -23,917 |
| Other Operating Activity | 18,991 | 37,537 | 25,445 | 20,738 | 18,887 |
| Operating Cash Flow | $20,570 | $93,942 | $71,365 | $37,185 | $-6,669 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -428 | -5,546 | -4,065 | -1,662 | -836 |
| Purchase Sale Intangibles | N/A | -368,226 | -368,226 | -368,226 | -366,811 |
| Other Investing Activity | 0 | -368,226 | -368,226 | -368,226 | -366,811 |
| Investing Cash Flow | $-428 | $-373,772 | $-372,291 | $-369,888 | $-367,647 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 330,394 | 330,394 | 330,394 | 138,794 |
| Debt Repayment | -12,500 | -49,000 | -36,500 | -24,000 | -11,500 |
| Common Stock Issued | 4,540 | 7,335 | 7,152 | 6,437 | 197,184 |
| Other Financing Activity | -3,508 | -2,255 | -2,169 | -1,922 | -1,358 |
| Financing Cash Flow | $-11,468 | $286,474 | $298,877 | $310,909 | $323,120 |
| Beginning Cash Position | 176,663 | 170,019 | 170,019 | 170,019 | 170,019 |
| End Cash Position | 185,337 | 176,663 | 167,970 | 148,225 | 118,823 |
| Net Cash Flow | $8,674 | $6,644 | $-2,049 | $-21,794 | $-51,196 |
| Free Cash Flow | |||||
| Operating Cash Flow | 20,570 | 93,942 | 71,365 | 37,185 | -6,669 |
| Capital Expenditure | -428 | -5,546 | -4,065 | -1,662 | -836 |
| Free Cash Flow | 20,142 | 88,396 | 67,300 | 35,523 | -7,505 |